Drug Trial Radar · NCT03878771
PRF in Management of Chronic Multiple Oral Ulcers
Last checked: Nov 19, 2026Latest source record: Sep 7, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
804
Actual
Start
Mar 13, 2019
Primary completion
Apr 15, 2019
Study completion Apr 15, 2019
Sponsor
- Lead sponsor
- Beni-Suef UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 18, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
PRF in orabase will be applied as a pack material on chronic oral ulcers of chronic multiple oral lesions compared to conventional topical steroid therapy with clobetasol propionate 0.05% in orabase. The outcomes measured are Pain alleviation as Primary outcome and Clinical improvement in terms of Ulcer size, Number and Mucositis score as Secondary outcomes. Time frame for outcomes assessment will be Daily for 7 Days regarding pain score and weekly for 2 weeks regarding clinical improvement.
Conditions
- Oral Ulcer Due to Pemphius Vularis
- Oral Ulcer Due to Benign Mucous Membrane Pemphioid
- Oral Ulcer Due to Steven Johnson's Syndrome
Interventions
Platelet rich fibrin gel in OrabaseBiological
applied on oral mucositis and /or ulcer 3 times per day
Dermovate cream in OrabaseDrug
applied on oral mucositis and /or ulcer 3 times per day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain scoreTime frame: 1 week
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Eman Ahmed
Banī Suwayf, Beni Suweif Governorate, Egypt
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.